Alpha-synuclein ligands
US12012394B2 · kind B2 · utility
0Cited by
8References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 15, 2019 |
| Grant date | Jun 18, 2024 |
| Priority date | — |
| Expiry date | Apr 13, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to various compounds that are useful as α-synuclein ligands. The invention further relates to methods of using these compounds and their radiolabeled analogs for the detection of synucleinopathies, including Parkinson's disease (PD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.